Bausch Health Companies Inc. - Bathi saben saham sajrone 12 wulan pungkasan BHC

Logo perusahaan publik Bausch Health Companies Inc. (BHC)

Bausch Health Companies (BHC) generates revenue from the sale of ophthalmology and gastroenterology products to various patient categories. Leveraging a powerful portfolio of Salix and Bausch + Lomb brands, the holding company allocates profits toward debt repayment, although massive debt continues to constrain growth. The current EPS TTM YoY growth rate on the GURU.Markets dynamic chart reflects the impact of borrowing costs, with the metric currently standing at -330.80.

BHC Bausch Health Companies Inc.: Bathi saben saham sajrone rolas wulan pungkasan ing interval 11.02.2024 - 17.11.2026

Bausch Health Companies - rincian analitis lan metrik utama (BHC)

- rega saham lan prakiraan rega para ahli:
Pambiji fundamental perusahaan:BHC - Valeant Pharmaceuticals
Produk mawa merek Bausch Health Corp

Production automation at Bausch Health Companies (BHC) optimizes costs, yet the efficiency of R&D and clinical trial investments translates directly into earnings per share dynamics. Analyzing the historical percentage growth of EPS YoY (TTM) allows for an assessment of the annual change in net income over 12 months, where sharp deviations in the curve signal a risk of declining solvency for the company despite a formally low asset valuation.